Lead counsel for Genentech against Columbia University which had demanded that Genentech license a patent for a widely used recombinant DNA technique for producing protein in a host cell.
Genentech sued the University for obviousness-type double patenting.
Mr. Quinn’s team obtained the University’s agreement to a broad covenant not to sue Genentech for past, current or future infringement of the patent or any reissued patent with the same or similar claims.